About the Post-Conference Report
  • This report provides an analysis of the 99 abstracts, assessed by drug target, author affiliation, and trial phase, followed by top level summaries grouped by clinical data, trial outline and preclinical data type.
  • Summaries have been created based on the data presented in the abstracts. Additional information from posters, where available, can be found on the associated Beacon trial or drug page.
  • Due to the large volume of preclinical data attached to each approved DDR asset we have worked with KOLs to curate a list of preclinical references, prioritizing approval data and publications. Hence, the following ASCO abstracts may not be visible on each respective drug page.

Find out more


This insight and data is part of the subscription to Beacon DDR.

Beacon DDR Logo


Find out more

Speak with our Team

Our dedicated Sales and Research teams can help you with questions by showing you how this insight and data is collated on Beacon

Frank Plowden  


Request a Demo

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.


Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more